What one share of Jazz Pharmaceuticals holds
Jazz Pharmaceuticals plc is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare disease – often with limited or no therapeutic options.
Jazz Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $71.56 |
|---|---|
| Profit | $14.63 |
| Capex (buildings and equipment) | $1.08 |
| Free cash flow | $24.75 |
| Cash and investments | $24.95 |
| Debt | $67.03 |
| Book value | $73.97 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $4.28 | −$0.23 | — | — | — | −$2.43 |
| 2010 | $4.41 | $0.83 | $0.02 | $1.48 | — | $0.76 |
| 2011 | $5.82 | $2.67 | $0.03 | $3.21 | — | $4.54 |
| 2012 | $9.73 | $4.79 | $0.10 | $4.05 | — | $19.33 |
| 2013 | $14.17 | $3.51 | $0.16 | $4.52 | — | $22.39 |
| 2014 | $18.73 | $0.93 | $0.58 | $5.93 | — | $22.61 |
| 2015 | $21.02 | $5.23 | $0.57 | $7.87 | — | $26.08 |
| 2016 | $24.05 | $6.41 | $0.16 | $9.42 | — | $31.38 |
| 2017 | $26.40 | $7.96 | $0.47 | $10.83 | — | $46.06 |
| 2018 | $30.89 | $7.30 | $0.33 | $12.72 | — | $47.79 |
| 2019 | $37.56 | $9.09 | $0.70 | $12.79 | — | $55.41 |
| 2020 | $41.82 | $4.22 | $0.27 | $15.65 | — | $65.15 |
| 2021 | $51.84 | −$5.52 | $0.46 | $12.58 | — | $64.34 |
| 2022 | $58.51 | −$3.58 | $0.46 | $19.87 | — | $48.81 |
| 2023 | $53.20 | $6.10 | $0.33 | $14.82 | — | $60.03 |
| 2024 | $61.64 | $8.65 | $0.58 | $20.57 | — | $67.52 |
| 2025 | $69.98 | −$5.84 | $0.96 | $21.27 | — | $70.30 |
Common questions about Jazz Pharmaceuticals
How much does one share of Jazz Pharmaceuticals earn?
Over the last 12 months, each share of Jazz Pharmaceuticals earned $14.63 of profit on $71.56 of sales, keeping about 20¢ of every $1 (profit margin).
Does Jazz Pharmaceuticals pay a dividend?
Jazz Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Jazz Pharmaceuticals’s book value per share?
Jazz Pharmaceuticals’s book value is $73.97 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Jazz Pharmaceuticals have?
Each share of Jazz Pharmaceuticals has $24.95 of cash and investments and $67.03 of debt, as of June 30, 2026.
What is Jazz Pharmaceuticals’s free cash flow per share?
$24.75 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Jazz Pharmaceuticals bought back shares?
Jazz Pharmaceuticals’s share count rose about 103% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.